Undiagnosed prediabetes may weaken PDE5i efficacy against erectile dysfunction
Phosphodiesterase type 5 inhibitors (PDE5is) have weaker efficacy in erectile dysfunction patients with undiagnosed pre-diabetes, a recent study has shown.
Undiagnosed prediabetes may weaken PDE5i efficacy against erectile dysfunction
19 Jul 2020